Teva Pharmaceuticals Initiates Voluntary Nationwide Recall of Seven Lots of Amikacin Sulfate Injection USP 500 mg/2 mL (250 mg/mL) and 1 Gram/4 mL (250 mg/mL) Vials Due to Potential of Glass Particulate Matter - FDA Safety Alerts & Drug Recalls

Teva Pharmaceuticals of North Wales, PA, today announced a voluntary recall of seven lots of Amikacin Sulfate Injection USP, 500 mg/2mL (250 mg/mL) and 1 gram/4mL (250 mg/mL) vials due to the potential for the presence of glass particulate matter.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2at6OiY
via IFTTT